{"id":46,"date":"2025-10-13T19:54:18","date_gmt":"2025-10-13T17:54:18","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&p=46"},"modified":"2026-05-21T22:52:08","modified_gmt":"2026-05-21T20:52:08","slug":"retatrutid","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/da\/shop\/retatrutide\/","title":{"rendered":"Retatrutid"},"content":{"rendered":"

Retatrutid - multireceptorpeptid til stofskifte- og v\u00e6gtkontrol<\/strong><\/p>\n

Sammens\u00e6tning: <\/strong>Retatrutid (fryset\u00f8rret peptidpulver)
Kategori:<\/strong> Peptid
Form:<\/strong> H\u00e6tteglas med fryset\u00f8rret pulver
Administration:<\/strong> Subkutan injektion efter rekonstitution med bakteriostatisk vand<\/p>\n

\n

Hvad er retatrutid?<\/h3>\n

Retatrutid er et avanceret, langtidsvirkende tredobbelt agonist-peptid<\/strong> der samtidig aktiverer GLP-1 (glukagonlignende peptid-1)<\/strong>, GIP (glukoseafh\u00e6ngigt insulinotropisk polypeptid)<\/strong>, og Glukagon-receptorer<\/strong>.
Den tilh\u00f8rer en ny generation af peptider til metabolisk forskning<\/strong> designet til at \u00f8ge energiforbruget<\/strong>, regulere appetitten<\/strong>, og forbedre glukose- og lipidmetabolismen<\/strong>.<\/p>\n

Gennem samtidig aktivering af flere metaboliske veje har retatrutid vist et bem\u00e6rkelsesv\u00e6rdigt potentiale i Pr\u00e6kliniske og kliniske unders\u00f8gelser<\/strong> Unders\u00f8gelse fedme, insulinresistens,<\/strong> og stofskiftesygdomme<\/strong>.<\/p>\n

\u27a1\ufe0f Ideel til energibalance, v\u00e6gtregulering,<\/strong> og peptidbaseret metabolisk modulation.<\/strong><\/p>\n

\n

Vigtige forskningsresultater<\/h3>\n

Tredobbelt receptoraktivering:<\/strong> Samtidig stimulering af GLP-1, GIP,<\/strong> og Glukagon-receptorer<\/strong> for \u00f8get metabolisk effektivitet.<\/p>\n

Regulering af appetit og energi:<\/strong> P\u00e5virker centrale mekanismer i appetitkontrol<\/strong> og fremmer kalorieforbrug<\/strong>.<\/p>\n

Glukose- og lipidmetabolisme:<\/strong> Underst\u00f8tter forbedret insulinf\u00f8lsomhed, glukosehomeostase,<\/strong> og fedtoxidation<\/strong>.<\/p>\n

Kroppens sammens\u00e6tning:<\/strong> Unders\u00f8gt for sit potentiale til at reducere kropsfedt<\/strong> mens bevarelse af mager masse<\/strong>.<\/p>\n

\n

Dosering og anvendelse<\/h3>\n

Rekonstituer med bakteriostatisk vand<\/strong> f\u00f8r brug.<\/p>\n

Typisk forskningsomr\u00e5de: 0,25-1,0 mg pr. p\u00e5f\u00f8ring<\/strong>, subkutant (afh\u00e6ngigt af unders\u00f8gelsesdesign).<\/p>\n

Hyppighed: Variabel, ofte 1-2 gange om ugen<\/strong> i langvarige metaboliske studier.<\/p>\n

Opbevar den rekonstituerede opl\u00f8sning nedk\u00f8let<\/strong> og brug inden for 30 dage<\/strong>.<\/p>\n

\n

Instruktioner for opbevaring<\/h3>\n
    \n
  • \n

    Opbevares p\u00e5 2-8 \u00b0C (36-46 \u00b0F)<\/strong><\/p>\n<\/li>\n

  • \n

    Beskyt mod lys og fugt<\/strong><\/p>\n<\/li>\n

  • \n

    M\u00e5 ikke fryses<\/strong><\/p>\n<\/li>\n

  • \n

    Undg\u00e5 temperatursvingninger<\/p>\n<\/li>\n<\/ul>\n

    \n

    Hvorfor v\u00e6lge Retatrutide?<\/h3>\n

    Retatrutid er en af de mest avancerede multi-agonist-peptider<\/strong> er i \u00f8jeblikket under efterforskning.
    Gennem sin synergistisk aktivering af GLP-1-, GIP- og glukagonreceptorer<\/strong>, Den giver et unikt indblik i hormonel regulering af energibalance, fedtmetabolisme og appetitkontrol<\/strong>.<\/p>\n

    Bestil Retatrutide <\/strong>\u00a0og udforske dets potentiale i n\u00e6ste generation af forskning i stofskifte og v\u00e6gtkontrol.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

    Retatrutide \u2013 Multi-Receptor Peptide for Metabolic & Weight Management Composition: Retatrutide (lyophilized peptide powder)Category: PeptideForm: Vial with freeze-dried powderAdministration: Subcutaneous injection after reconstitution with bacteriostatic water What is Retatrutide? Retatrutide is an advanced, long-acting triple agonist peptide that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and Glucagon receptors.It belongs to a new generation of metabolic research peptides designed to increase energy expenditure, regulate appetite, and improve glucose and lipid metabolism. Through the simultaneous activation of multiple metabolic pathways, Retatrutide has shown remarkable potential in preclinical and clinical studies investigating obesity, insulin resistance, and metabolic disorders. \u27a1\ufe0f Ideal for energy balance, weight regulation, and peptide-based metabolic modulation. Key Research Findings Triple Receptor Activation: Simultaneous stimulation of GLP-1, GIP, and Glucagon receptors for enhanced metabolic efficiency. Appetite & Energy Regulation: Influences central mechanisms of appetite control and promotes caloric expenditure. Glucose & Lipid Metabolism: Supports improved insulin sensitivity, glucose homeostasis, and fat oxidation. Body Composition: Studied for its potential to reduce body fat while preserving lean mass. Dosage & Application Reconstitute with bacteriostatic water before use. Typical research range: 0.25\u20131.0 mg per application, subcutaneously (depending on study design). Frequency: Variable, often 1\u20132 times per week in long-term metabolic studies. Store the reconstituted solution refrigerated and use within 30 days. Storage Instructions Store at 2\u20138 \u00b0C (36\u201346 \u00b0F) Protect from light and moisture Do not freeze Avoid temperature fluctuations Why Choose Retatrutide? Retatrutide is one of the most advanced multi-agonist peptides currently under investigation.Through its synergistic activation of GLP-1, GIP, and Glucagon receptors, it provides unique insights into the hormonal regulation of energy balance, fat metabolism, and appetite control. Order Retatrutide \u00a0and explore its potential in the next generation of metabolic and weight management research.<\/p>","protected":false},"featured_media":59,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,24,25,27],"product_tag":[],"class_list":{"0":"post-46","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-all-products","7":"product_cat-glp-1andmultiagonist","8":"product_cat-metabolismandweightmanagement","9":"product_cat-peptidesandresearchdrugs","10":"entry","11":"has-media","13":"first","14":"instock","15":"sale","16":"purchasable","17":"product-type-variable"},"acf":[],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/europa-peptide.com\/da\/wp-json\/wp\/v2\/product\/46","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europa-peptide.com\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europa-peptide.com\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/da\/wp-json\/wp\/v2\/comments?post=46"}],"version-history":[{"count":3,"href":"https:\/\/europa-peptide.com\/da\/wp-json\/wp\/v2\/product\/46\/revisions"}],"predecessor-version":[{"id":28952,"href":"https:\/\/europa-peptide.com\/da\/wp-json\/wp\/v2\/product\/46\/revisions\/28952"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/da\/wp-json\/wp\/v2\/media\/59"}],"wp:attachment":[{"href":"https:\/\/europa-peptide.com\/da\/wp-json\/wp\/v2\/media?parent=46"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europa-peptide.com\/da\/wp-json\/wp\/v2\/product_brand?post=46"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europa-peptide.com\/da\/wp-json\/wp\/v2\/product_cat?post=46"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europa-peptide.com\/da\/wp-json\/wp\/v2\/product_tag?post=46"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}